S. Imbevaro

Metastatic Medullary Thyroid Cancer, Somatostatin Analogues and Markers

M. Pelizzo, A. Fassina, M. Boscaro, 2016 .

PPA_A_351771 353..362

V. Zagonel, D. Costardi, S. Lonardi, 2022 .

The impact of new cancer drugs in real practice oncology: a monoinstitutional experience

A. Jirillo, M. Mazurek, S. Imbevaro, 2012, Immunopharmacology and immunotoxicology.

Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two Institutions

P. Terrier, A. D. Dei Tos, A. Le Cesne, 2020, Frontiers in Oncology.

Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology

V. Zagonel, D. Costardi, S. Lonardi, 2022, Patient preference and adherence.

Genitourinary tumors, non-prostate

S. J. Park, I. Tannock, S. Groshen, 2012 .

The Economic Crisis and Cancer Chemotherapy: The Role of the Oncologist

A. Jirillo, P. Rescigno, S. Imbevaro, 2012, Tumori.